These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18675614)

  • 21. Primary mental health care information and services for St. John's visible minority immigrants: gaps and opportunities.
    Reitmanova S; Gustafson DL
    Issues Ment Health Nurs; 2009 Oct; 30(10):615-23. PubMed ID: 19742371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to engage the Latino or African American patient with benign prostatic hyperplasia: crossing socioeconomic and cultural barriers.
    Martinez M; Maislos S; Rayford W
    Am J Med; 2008 Aug; 121(8 Suppl 2):S11-7. PubMed ID: 18675612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving communication in a diverse healthcare environment.
    Thiederman S
    Healthc Financ Manage; 1996 Nov; 50(11):72, 74-5. PubMed ID: 10162352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [TUBVP and HOLEP: desirable surgical options for large benign prostatic hyperplasia ( >80 ml)].
    Zhu QY; Gu XJ; Yuan L; Huang WZ; Zhang L; Lu ZJ; Zhang P; Su J; Xu Y; Zhang Y
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):907-10. PubMed ID: 19157101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity in academic medicine no. 1 case for minority faculty development today.
    Nivet MA; Taylor VS; Butts GC; Strelnick AH; Herbert-Carter J; Fry-Johnson YW; Smith QT; Rust G; Kondwani K
    Mt Sinai J Med; 2008 Dec; 75(6):491-8. PubMed ID: 19021210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Separate and unequal: clinics where minority and nonminority patients receive primary care.
    Varkey AB; Manwell LB; Williams ES; Ibrahim SA; Brown RL; Bobula JA; Horner-Ibler BA; Schwartz MD; Konrad TR; Wiltshire JC; Linzer M;
    Arch Intern Med; 2009 Feb; 169(3):243-50. PubMed ID: 19204215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical management of benign prostatic hyperplasia: current evidence.
    Baazeem A; Elhilali MM
    Nat Clin Pract Urol; 2008 Oct; 5(10):540-9. PubMed ID: 18836463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Using setegis (terasosine) in early postoperative period after transurethral prostate resection].
    Teodorovich OV; Zabrodina NB; Bochkarev AB
    Urologiia; 2009; (3):62-4. PubMed ID: 19673124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward improved rehabilitation services for ethnically diverse survivors of traumatic brain injury.
    Niemeier J; Carlos Arango-Lasprilla J
    J Head Trauma Rehabil; 2007; 22(2):75-84. PubMed ID: 17414309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia.
    Nichol MB; Knight TK; Wu J; Barron R; Penson DF
    J Urol; 2009 May; 181(5):2214-21; discussion 2221-2. PubMed ID: 19296986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of nurse practitioner cultural competence on Latina patient satisfaction.
    Castro A; Ruiz E
    J Am Acad Nurse Pract; 2009 May; 21(5):278-86. PubMed ID: 19432912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (Mis)understanding in patient-health care provider communication about total knee replacement.
    Street RL; Richardson MN; Cox V; Suarez-Almazor ME
    Arthritis Rheum; 2009 Jan; 61(1):100-7. PubMed ID: 19116969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
    Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
    Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
    Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
    Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel idea in BPH guideline: the patient as decision maker.
    Roberts RG
    Am Fam Physician; 1994 Apr; 49(5):1044-6, 1051. PubMed ID: 7512307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.